Nat. Immunity Prevents Delta Better Than Vaccine

By Michelle Fay Cortez August 27, 2021, 1:38 AM EDT BLOOMBERG Early data from Israel shows natural immunity wanes with time People who recovered from Covid may face lower risk from delta People who recovered from a bout of Covid-19 during one of the earlier waves of the pandemic appear to have a lower risk…

SHARE:
Read More

Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases

January 2021   We sought to determine whether immune reactivity occurs between anti-SARS-CoV-2 protein antibodies and human tissue antigens, and whether molecular mimicry between COVID-19 viral proteins and human tissues could be the cause. We applied both human monoclonal anti-SARS-Cov-2 antibodies (spike protein, nucleoprotein) and rabbit polyclonal anti-SARS-Cov-2 antibodies (envelope protein, membrane protein) to 55…

SHARE:
Read More

The Safety of COVID-19 Vaccinations—We Should Rethink the Policy

Abstract: Background: COVID-19 vaccines have had expedited reviews without sufficient safety data. We wanted to compare risks and benefits. Method: We calculated the number needed to vaccinate (NNTV) from a large Israeli field study to prevent one death. We accessed the Adverse Drug Reactions (ADR) database of the European Medicines Agency and of the Dutch National Register (lareb.nl) to…

SHARE:
Read More

Israel sees probable link between Pfizer vaccine and myocarditis cases

Israel’s Health Ministry said on Tuesday it had found the small number of heart inflammation cases observed mainly in young men who received Pfizer’s (PFE.N) COVID-19 vaccine in Israel were likely linked to their vaccination. Pfizer said in a statement that it was aware of the Israeli observations of myocarditis and said no causal link…

SHARE:
Read More

Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies

Wen Shi Lee, Adam K. Wheatley, Stephen J. Kent & Brandon J. DeKosky Nature Microbiology Abstract Antibody-based drugs and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being expedited through preclinical and clinical development. Data from the study of SARS-CoV and other respiratory viruses suggest that anti-SARS-CoV-2 antibodies could exacerbate COVID-19 through antibody-dependent enhancement…

SHARE:
Read More

Study of Almost 10 Million Finds NO ASYMPTOMATIC COVID SPREAD; Media Silent

by Selwyn Duke December 22, 2020 Whether or not coronavirus can be spread asymptomatically is perhaps the most important question surrounding the disease. After all, the assumption that it can has been used to justify mask mandates and life-ravaging lockdowns. This is why it’s striking that a major study, involving almost 10 million people, has…

SHARE:
Read More

Mask Effectiveness

Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial   Abstract Background: Observational evidence suggests that mask wearing mitigates transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is uncertain if this observed association arises through protection of uninfected…

SHARE:
Read More

Study finds over 80 percent of COVID-19 patients have vitamin D deficiency

Washington, DC October 27, 2020 Vitamin D deficiency was more prevalent in men Over 80 percent of 200 COVID-19 patients in a hospital in Spain have vitamin D deficiency, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Vitamin D is a hormone the kidneys produce that controls blood calcium concentration and impacts the immune system. Vitamin D deficiency has been linked to a variety of…

SHARE:
Read More